Eye Institute of Xiamen University and Affiliated Xiamen Eye Center, School of Medicine, Xiamen University, Xiamen, China.
Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Xiamen, China.
Tissue Eng Part A. 2022 Dec;28(23-24):977-989. doi: 10.1089/ten.TEA.2022.0082. Epub 2022 Nov 4.
Tissue-engineered corneal epithelium transplantation is effective treatment for severe limbal stem cell deficiency (LSCD), while epithelial terminal differentiation, tans-differentiation, and insufficient stem cell during construction affect the quality of tissue-engineered corneal epithelium. In this study, we applied SB203580 in the culture medium to downregulate the p38 mitogen-activated protein kinase (MAPK) signaling pathway during construction of tissue-engineered corneal epithelium. With application of SB203580, tissue-engineered corneal epithelium showed enhanced strength and condensed structure. The expression of progenitor cell markers ATP-binding cassette sub-family G member 2, tumor protein p63, keratin 14, and Wnt family member 7A was increased, differentiation markers keratin 12, paired box 6, keratin 10, and keratin 13 and trans-differentiation markers actin alpha 2, smooth muscle and snail family transcriptional repressor 1 was decreased, while cell junction markers claudin 1 and cadherin 1 was increased in the tissue-engineered corneal epithelium. The Wnt/catenin beta 1 signaling pathway was upregulated in the epithelium after p38 MAPK inhibition. Transplantation of tissue-engineered corneal epithelium treated with SB203580 to rabbit LSCD model showed faster wound healing and improved epithelial quality. We conclude that downregulation of p38 MAPK signaling pathway helps maintain the stemness and prevent terminal differentiation and abnormal differentiation of corneal epithelial cells during epithelium construction process, and thus can improve the quality of tissue-engineered corneal epithelium. Impact statement Downregulation of p38 MAPK signaling pathway helps maintain the self-renewal of limbal stem cells and prevents terminal differentiation and abnormal differentiation of corneal epithelial cells. Small molecules modulating p38 MAPK signaling pathway ameliorate tissue-engineered corneal epithelium.
组织工程化角膜上皮移植是治疗严重角膜缘干细胞缺乏症(LSCD)的有效方法,然而在构建组织工程化角膜上皮的过程中,上皮细胞的终末分化、转分化以及干细胞不足会影响组织工程化角膜上皮的质量。本研究在构建组织工程化角膜上皮的过程中,在培养基中应用 SB203580 下调 p38 丝裂原活化蛋白激酶(MAPK)信号通路。应用 SB203580 后,组织工程化角膜上皮的强度和结构更加紧密。前体细胞标志物 ATP 结合盒亚家族 G 成员 2、肿瘤蛋白 p63、角蛋白 14 和 Wnt 家族成员 7A 的表达增加,分化标志物角蛋白 12、配对盒 6、角蛋白 10 和角蛋白 13 以及转分化标志物肌动蛋白α 2、平滑肌和 snail 家族转录阻遏物 1 的表达减少,而细胞连接标志物 Claudin 1 和 Cadherin 1 的表达增加。p38 MAPK 抑制后,上皮细胞中的 Wnt/β-catenin 信号通路被上调。将经 SB203580 处理的组织工程化角膜上皮移植到兔 LSCD 模型中,显示出更快的伤口愈合和改善的上皮质量。我们的结论是,下调 p38 MAPK 信号通路有助于维持角膜缘干细胞的干性,防止角膜上皮细胞的终末分化和异常分化,从而提高组织工程化角膜上皮的质量。